HFA
GILD icon

Hoover Financial Advisors’s Gilead Sciences GILD Stock Holding History

Hoover Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1K Sell
20
-33
-62% -$2.2K ﹤0.01% 610
2021
Q1 		$4K Buy
53
+8
+18% +$516 ﹤0.01% 503
2020
Q4 		$3K Buy
+45
New +$2.71K ﹤0.01% 482
2020
Q3 		– Sell
-45
Closed -$3K – 302
2020
Q2 		$3K Buy
+45
New +$3.45K ﹤0.01% 422

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Hoover Financial Advisors's GILD Position: Q2 2021 in Review

Hoover Financial Advisors reduced its Gilead Sciences (GILD) stake by 62% in Q2 2021, selling an estimated $2.2K and leaving 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #610.

Hoover Financial Advisors first reported a position in GILD in Q2 2020 and has held it in 4 quarters since. The position peaked at $4K in Q1 2021. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Hoover Financial Advisors held 20 shares of Gilead Sciences worth $1K as of Q2 2021.
  • Hoover Financial Advisors sold 33 Gilead Sciences shares in Q2 2021, an estimated $2.2K.
  • Gilead Sciences made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #610 holding.
  • Hoover Financial Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 4 quarters since.
  • Hoover Financial Advisors's Gilead Sciences position peaked at $4K in Q1 2021.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.